Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures.

ABSTRACT: Lower urinary tract symptoms due to benign prostatic hyperplasia constitute a substantial burden, affecting the quality of life of those affected by this condition. While watchful waiting and medical management using a wide array of pharmaceuticals can be effective, surgery has been one of the most definite solutions for those highly affected by this condition. Transurethral resection of the prostate (TURP) is the gold standard surgical procedure, but other alternatives using laser (HoLEP and ThuLEP) and robotic water jets (Aquablation) are emerging treatments aimed at reducing postoperative morbidity. Minimally invasive procedures conducted in outpatient settings and under local anesthesia or sedation are increasingly being used, especially in those patients with high surgical risk due to

SUBMITTER: Franco JVA 

PROVIDER: S-EPMC9995694 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature